McQuaid A, Tormey V J, Trafford B, Webster A D, Bofill M
Department of Immunology, Royal Free Hospital, Pond Street, London, UK.
Clin Exp Immunol. 2003 Nov;134(2):321-7. doi: 10.1046/j.1365-2249.2003.02271.x.
We investigated the expression of T helper (Th)1/Th2 regulatory cytokine receptors on lymphocytes from patients with common variable immunodeficiency (CVID), a disorder associated with raised Th1 cytokine production, comparing the results with those from healthy individuals and atopic asthmatics, the latter generally considered to have a Th2-driven disease. We proposed that alterations in some of the relevant receptors might be related to the observed imbalances in Th1/Th2 cytokines. Cells from CVID patients showed an increase in the percentages of CD212 [interleukin (IL)-12Rbeta1] cells within the CD4+ CD45RA+ and CD8+ CD45RA+ subsets (24% and 41%, respectively), as compared to CD4+ CD45RA+ and CD8+ CD45RA+ in healthy subjects (6% and 23%, respectivey). Approximately 21% of the CD4+ CD45RA+ naïve cells expressed IL-18Ralpha, compared with 11% in healthy subjects. In contrast, the cytokine-receptor expression in asthmatics was similar to that of controls. In spite of the above differences, after 72 h of stimulation with anti-CD3 and anti-CD28, cytokine receptor up-regulation was similar in all three groups, with up to 80% of both CD45RA+ and CD45RO+ lymphocytes expressing CD212 (IL-12Rbeta1) and IL-18Ralpha. Approximately 50% of the 'naïve', and 25% of the 'memory' subpopulations up-regulated IL-12Rbeta2. These findings provide further evidence of a polarization towards a Th1 immune response in CVID, the mechanism possibly involving up-regulation of IL-12-mediated pathways.
我们研究了常见可变免疫缺陷(CVID)患者淋巴细胞上辅助性T细胞(Th)1/Th2调节性细胞因子受体的表达情况,该疾病与Th1细胞因子产生增加有关,并将结果与健康个体和特应性哮喘患者进行比较,后者通常被认为是由Th2驱动的疾病。我们推测某些相关受体的改变可能与观察到的Th1/Th2细胞因子失衡有关。与健康受试者的CD4+ CD45RA+和CD8+ CD45RA+细胞(分别为6%和23%)相比,CVID患者的细胞在CD4+ CD45RA+和CD8+ CD45RA+亚群中CD212[白细胞介素(IL)-12Rβ1]细胞的百分比增加(分别为24%和41%)。约21%的CD4+ CD45RA+初始细胞表达IL-18Rα,而健康受试者中这一比例为11%。相比之下,哮喘患者的细胞因子受体表达与对照组相似。尽管存在上述差异,但在用抗CD3和抗CD28刺激72小时后,三组中细胞因子受体的上调情况相似,高达80%的CD45RA+和CD45RO+淋巴细胞表达CD212(IL-12Rβ1)和IL-18Rα。约50%的“初始”亚群和25%的“记忆”亚群上调了IL-12Rβ2。这些发现进一步证明了CVID中向Th1免疫反应的极化,其机制可能涉及IL-12介导途径的上调。